Physician profile
Martin P Michalewski
NPI 1164410643
$2,196.69
in general payments reported to CMS, 2019-2025
19 companies · $46.60 in 2025
The $46.60 reported for 2025 was less than what a typical Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) provider received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $826 · 2020: $66.55 · 2021: $144 · 2022: $96.05 · 2023: $225 · 2024: $793 · 2025: $46.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $552 · Food and Beverage: $494 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $551.61 |
| Food and Beverage | $493.81 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bluewind Medical | $768.02 | 2024 | Revi |
| Asensus Surgical, INC. | $437.33 | 2019 | |
| Boston Scientific Corporation | $219.51 | 2019-2022 | |
| Axonics, INC. | $148.66 | 2020-2023 | Axonics |
| Pfizer INC. | $111.28 | 2019-2023 | |
| Astellas Pharma US INC | $97.25 | 2019-2023 | Veozah |
| Coloplast Corp | $67.07 | 2021 | |
| Femselect INC. | $65.08 | 2023 | Enplace |
| Escala Medical INC. | $46.60 | 2025 | |
| Medtronic, INC. | $38.95 | 2022-2023 | Interstim |
| Astrazeneca Pharmaceuticals LP | $35.58 | 2019 | |
| Viiv Healthcare Company | $26.91 | 2020-2021 | |
| Intuitive Surgical, INC. | $24.95 | 2024 | |
| Novo Nordisk INC | $21.84 | 2023 | Ozempic |
| Baudax Bio INC. | $21.21 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Innovation Technologies INC | $20.00 | 2022 | |
| Stryker Corporation | $19.22 | 2020 | |
| Medtronic USA, INC. | $15.39 | 2020 | |
| Alkermes, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Martin Michalewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.